Search:
		Advances in MS: Management of Side Effects of Treatments for Multiple Sclerosis Featured Panelists Peter Calabresi, MD Steven Galetta, MD Mitch Freedman, MD Dusan Stefoski, MD Disease-modifying therapies (interferon, glatiramer and mitoxantrone) are the mainstay in the treatment of multiple sclerosis (MS). Patients may develop side effects, however, that need to be treated aggressively to ensure that they derive maximum benefit from these medications through compliance and persistency. Windows Me / XP / 2000 800 MHz P3 processor 256 MB RAM Microsoft Internet Explorer (6.0 or higher) 16-bit sound card and Windows Media Player (9.0 or greater) Video Card capable of 16bit color Adobe Acrobat 6.0 or greater Click Here to Proceed to Program
	Resources  |  About Us  |  Contact Us  |  Privacy Policy  |  Disclaimer  |  Editorial & Sponsorship Policy  |  Terms of Use Search: